华邦健康：全资子公司获得《药品注册证书》

Core Points - Huabang Health announced that its wholly-owned subsidiary, Chongqing Huabang Pharmaceutical Co., Ltd., has received the drug registration certificates for two specifications of Mometasone Furoate Cream from the National Medical Products Administration [2] Group 1 - The approval of Mometasone Furoate Cream is a significant milestone for the company, enhancing its product portfolio in the pharmaceutical sector [2] - The registration certificates indicate compliance with regulatory standards, which may facilitate market entry and sales growth for the company [2]